Show full item record

Permalink

http://hdl.handle.net/10138/323955

Citation

Malani , D , Yadav , B , Kumar , A , Potdar , S , Kontro , M , Kankainen , M , Javarappa , K K , Porkka , K , Wolf , M , Aittokallio , T , Wennerberg , K , Heckman , C A , Murumägi , A & Kallioniemi , O 2020 , ' KIT pathway upregulation predicts dasatinib efficacy in acute myeloid leukemia ' , Leukemia , vol. 34 , no. 10 , 34 , pp. 2780–2784 . https://doi.org/10.1038/s41375-020-0978-7

Title:	KIT pathway upregulation predicts dasatinib efficacy in acute myeloid leukemia
Author:	Malani, Disha; Yadav, Bhagwan; Kumar, Ashwini; Potdar, Swapnil; Kontro, Mika; Kankainen, Matti; Javarappa, Komal K.; Porkka, Kimmo; Wolf, Maija; Aittokallio, Tero; Wennerberg, Krister; Heckman, Caroline A.; Murumägi, Astrid; Kallioniemi, Olli
Contributor organization:	Precision Systems Medicine Institute for Molecular Medicine Finland Helsinki Institute of Life Science HiLIFE University of Helsinki HUS Comprehensive Cancer Center Department of Oncology Hematologian yksikkö HUSLAB Research Programs Unit Department of Medicine Tero Aittokallio / Principal Investigator Bioinformatics Krister Wennerberg / Principal Investigator
Date:	2020-07-17
Language:	eng
Number of pages:	4
Belongs to series:	Leukemia
ISSN:	0887-6924
DOI:	https://doi.org/10.1038/s41375-020-0978-7
URI:	http://hdl.handle.net/10138/323955
Subject:	SENSITIVITY 3122 Cancers
Peer reviewed:	Yes
Usage restriction:	openAccess
Self-archived version:	acceptedVersion



Files in this item

Total number of downloads: Loading...

Files	Size	Format	View
Malani_manuscript_final_fig_suppl_text.pdf	1.124Mb	PDF	View/Open

This item appears in the following Collection(s)

• Articles from TUHAT system [53268]
  

Show full item record